Produkty 289054-34-8

CAS 289054-34-8 występuje w naszej ofercie pod nazwami: Ergosta-5,24(28)-diene-3,7,16-triol, Ergosta-5,24(28)-diene-3β,7α,16β-triol. Oferty producentów: Biosynth, MedChemExpress. Dostępne opakowania: 5mg, 2mg, 10mg, 25mg, Get quote.

Ergosta-5,24(28)-diene-3,7,16-triol
Biosynth
  • opakowanie: 5mg, 2mg, 10mg, 25mg
  • Warianty: 4
Zobacz produkt
Ergosta-5,24(28)-diene-3β,7α,16β-triol
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,7S,8S,9S,10R,13S,14S,16S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7,16-triol (CAS 289054-34-8) to związek chemiczny o wzorze sumarycznym C28H46O3 i masie molowej 430.7 g/mol. Nazwa systematyczna IUPAC: (3S,7S,8S,9S,10R,13S,14S,16S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7,16-triol. InChIKey: TYAFBMTZMSJDIO-LOCPLYNGSA-N.

Dane identyfikacyjne
Wzór sumarycznyC28H46O3
Masa molowa430.7 g/mol
Nazwa IUPAC(3S,7S,8S,9S,10R,13S,14S,16S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7,16-triol
InChIKeyTYAFBMTZMSJDIO-LOCPLYNGSA-N
SMILESC[C@H](CCC(=C)C(C)C)[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C=C4[C@@]3(CC[C@@H](C4)O)C)O)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Ergosta-5,24(28)-diene-3,7,16-triol, orb1682643, Ergosta-5,24(28)-diene-3, Ergosta-5,24(28)-diene-3,7,16-triol, (3,7,16)-, Ergosta-5,24(28)-diene-3,7,16-triol, (3|A,7|A,16|A)- (9CI), Ergosta-5,24(28)-diene-3,7,16-triol, (3beta,7alpha,16beta)- (9CI)
Izomery (ten sam wzór sumaryczny)
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-7-hydroxy-7-methyloctan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol C28H46O3
[(5S,8R,9R,10S,13S,14S)-13-methyl-3-oxo-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] decanoate C28H46O3
5-[(Z)-octadec-9-enoxy]-2-phenyl-1,3-dioxane C28H46O3
trans-(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S)-6-hydroxy-6-methyloctan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol C28H46O3
2-[(3S,8S,9S,10S,13R,14S,17R)-3-hydroxy-13-methyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]acetic acid C28H46O3
(3S,4S,5S,9R,10S,13R,14R,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-4-carboxylic acid C28H46O3
(1R,3aR,4R,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-4-[(1R,2Z)-1-hydroxy-2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ol C28H46O3
(1S,2R,5R,6R,9R,10R,13S,15S)-5-[(2R,5S)-5,6-dimethylheptan-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.01,9.02,6.010,15]nonadec-18-en-13-ol C28H46O3
(3S,5R,6R,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,3,4,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,5,6-triol C28H46O3